These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3984061)

  • 21. Omeprazole.
    Friedman G
    Am J Gastroenterol; 1987 Mar; 82(3):188-91. PubMed ID: 3548325
    [No Abstract]   [Full Text] [Related]  

  • 22. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
    Habal FM; Soldin SJ; Greenberg GR
    Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety aspects of omeprazole.
    Sölvell L
    Scand J Gastroenterol Suppl; 1986; 118():129-35. PubMed ID: 3460168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Omeprazole and peptic ulcer. Profile of a new active agent].
    Müller P; Dammann HG; Simon B
    Fortschr Med; 1987 Jan; 105(2):35-8. PubMed ID: 3557254
    [No Abstract]   [Full Text] [Related]  

  • 25. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possibilities of the use of present-day antisecretory preparation omeprazole].
    Degtiareva II; Semeunovich S; Kharchenko NV; Petrovich S; Gaĭsenko AV; Egorova IT
    Klin Med (Mosk); 1994; 72(6):38-40. PubMed ID: 7898006
    [No Abstract]   [Full Text] [Related]  

  • 27. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.
    Raufman JP; Collins SM; Pandol SJ; Korman LY; Collen MJ; Cornelius MJ; Feld MK; McCarthy DM; Gardner JD; Jensen RT
    Gastroenterology; 1983 Jan; 84(1):108-13. PubMed ID: 6128284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ranitidine and cimetidine in Zollinger-Ellison syndrome].
    Ribera E; González-Atienza J
    Med Clin (Barc); 1983 Dec; 81(20):924-5. PubMed ID: 6319838
    [No Abstract]   [Full Text] [Related]  

  • 29. Zollinger-Ellison syndrome, prolonged cimetidine administration and nasopharyngeal carcinoma:--a coincidence?
    Eshchar J; Neuman MG; Pavlotzky M; Saibil FG
    Int J Tissue React; 1983; 5(4):411-4. PubMed ID: 6323340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical treatment of Zollinger-Ellison syndrome with ranitidine.
    Vezzadini P; Bonora G; Tomassetti P; Pazzaglia M; Labò G
    Int J Tissue React; 1983; 5(4):339-43. PubMed ID: 6323334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Continuous recording of gastric pH to assess the efficacy of antisecretory drugs in Zollinger-Ellison syndrome].
    Galmiche JP; Mignon M; Ducrotte P; Mayeur S; Arsene D; Vallot T
    Nouv Presse Med; 1981 Feb; 10(6):432-3. PubMed ID: 6111787
    [No Abstract]   [Full Text] [Related]  

  • 32. Zollinger-Ellison syndrome with esophagitis and Barrett mucosa.
    Karl TR; Pindyck F; Sicular A
    Am J Gastroenterol; 1983 Oct; 78(10):611-4. PubMed ID: 6624733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
    Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
    Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
    Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S
    Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608
    [No Abstract]   [Full Text] [Related]  

  • 35. Zollinger-Ellison Syndrome.
    Reddy AB
    J Med Assoc State Ala; 1982 Oct; 52(4):49, 52, 54. PubMed ID: 7142852
    [No Abstract]   [Full Text] [Related]  

  • 36. Losec (omeprazole/MSD).
    Swartz ML
    Gastroenterol Nurs; 1990; 12(4):274-6. PubMed ID: 2288939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zollinger-Ellison syndrome. Streptozotocin therapy for metastatic gastrinomas.
    Huard GS; Stephens RL; Friesen SR
    J Kans Med Soc; 1981 May; 82(5):216-21. PubMed ID: 6453914
    [No Abstract]   [Full Text] [Related]  

  • 38. [Zollinger-Ellison syndrome. Experience in 14 cases and a review of the recent literature].
    Sitges Serra A
    Med Clin (Barc); 1984 Oct; 83(13):550-6. PubMed ID: 6151036
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
    Jansen JB; Lamers CB
    Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretin-induced gastrin response in the Zollinger-Ellison syndrome and chronic duodenal ulcer patients before and after cimetidine treatment.
    Quatrini M; Basilisco G; Conte D; Bardella MT; Bozzani A; Bianchi PA
    Am J Gastroenterol; 1984 May; 79(5):345-7. PubMed ID: 6720654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.